But $210,000,000 is quite achievable. I'm only counting US, not Canada or Europe I'm only assuming 30% of Opioid market to be ARTs/ADT's I'm only assuming 10% market share of the ART/ADT market in the US.
...and even with all of that we have a 50 fold increase in sales.